IIQ 0.88% 56.5¢ inoviq ltd

My take is this is seperate to the SubB2M program. EXO-NET is a...

  1. 25 Posts.
    lightbulb Created with Sketch. 13
    My take is this is seperate to the SubB2M program. EXO-NET is a platform technology used for isolating the relevant exosomes from the sample in question i.e., blood sample from a potential / suspected ovarian cancer patient. The assay UQ will be develop will to detect the relevant exosome marker in question.

    Please also note that releasing news of signing a CRO for the SubB2M program is also no guarantee. Will they tech transfer a test developed in the iNOVIQ lab (ELISA / IHC) and if so, optimisation, validation and test readiness under a NATA / CAP accredited lab will need to be completed in roughly 12 - 18 months if we are to see an LDT launch in 2023. Importantly, are they manufacturing a research grade SubB2M product in the meantime in order to provide to the CRO to test in the developed assay?

    Last edited by JollyRoger56: 01/04/22
 
watchlist Created with Sketch. Add IIQ (ASX) to my watchlist
(20min delay)
Last
56.5¢
Change
-0.005(0.88%)
Mkt cap ! $59.61M
Open High Low Value Volume
56.0¢ 60.0¢ 55.5¢ $78.24K 138.2K

Buyers (Bids)

No. Vol. Price($)
2 20037 56.5¢
 

Sellers (Offers)

Price($) Vol. No.
59.0¢ 2003 1
View Market Depth
Last trade - 15.32pm 09/07/2024 (20 minute delay) ?
IIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.